These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17687294)

  • 1. China tightens up.
    Qiu J
    Nature; 2007 Aug; 448(7154):636-7. PubMed ID: 17687294
    [No Abstract]   [Full Text] [Related]  

  • 2. China syndrome--a regulatory framework in meltdown?
    Jia H
    Nat Biotechnol; 2007 Aug; 25(8):835-7. PubMed ID: 17687350
    [No Abstract]   [Full Text] [Related]  

  • 3. [Editorial Letter. Drug approval].
    Borvendég J
    Neuropsychopharmacol Hung; 2011 Jun; 13(2):54-5. PubMed ID: 21919287
    [No Abstract]   [Full Text] [Related]  

  • 4. Executed Chinese drug czar corrupted by system, observers say.
    Cyranoski D
    Nat Med; 2007 Aug; 13(8):889. PubMed ID: 17679990
    [No Abstract]   [Full Text] [Related]  

  • 5. New modalities of prescription of ATUns: Evolutions and revolution.
    Vignot S; Plaine G; Chapel E
    Rev Neurol (Paris); 2020 May; 176(4):290-292. PubMed ID: 31611006
    [No Abstract]   [Full Text] [Related]  

  • 6. Prescription drug approval in Canada: a risk-benefit analysis.
    Davis T
    J Can Dent Assoc; 1995 Jul; 61(7):578-9. PubMed ID: 7627885
    [No Abstract]   [Full Text] [Related]  

  • 7. New drug approval process in Japan.
    Hayakawa T
    Curr Opin Biotechnol; 1999 Jun; 10(3):307-11. PubMed ID: 10361082
    [No Abstract]   [Full Text] [Related]  

  • 8. EMEA struggles with need to restructure.
    Sheridan C
    Nat Biotechnol; 2003 Oct; 21(10):1118-9. PubMed ID: 14520381
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug review "behind the curtain": a response to Professor Struve.
    O'Reilly JT
    Cornell Law Rev; 2008 Jul; 93(5):1075-90. PubMed ID: 18618971
    [No Abstract]   [Full Text] [Related]  

  • 10. [France in the European cooperation for the technological evaluation of health products].
    Meyer F
    Med Sci (Paris); 2018 May; 34 Hors série n°1():57-59. PubMed ID: 29911568
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristics of expedited programmes for cancer drug approval in China.
    Li G; Liu Y; Xie C; Zhou Q; Chen X
    Nat Rev Drug Discov; 2021 Jun; 20(6):416. PubMed ID: 33972774
    [No Abstract]   [Full Text] [Related]  

  • 12. Lessons from expanded government enforcement efforts against drug companies.
    Scheineson MJ; Klinger ST
    Food Drug Law J; 2005; 60(1):1-16. PubMed ID: 15940851
    [No Abstract]   [Full Text] [Related]  

  • 13. Oncology drug clinical development and approval in Japan: the role of the pharmaceuticals and medical devices evaluation center (PMDEC).
    Fujiwara Y; Kobayashi K
    Crit Rev Oncol Hematol; 2002 May; 42(2):145-55. PubMed ID: 12007972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Government report critical of FDA blasted as misleading.
    Fox JL
    Nat Biotechnol; 2008 Jan; 26(1):7. PubMed ID: 18183001
    [No Abstract]   [Full Text] [Related]  

  • 15. [Health technology assessment in the field of rare diseases at Haute Autorité de Santé in France].
    Bélorgey C
    Med Sci (Paris); 2018 May; 34 Hors série n°1():49-50. PubMed ID: 29911564
    [No Abstract]   [Full Text] [Related]  

  • 16. Bush tails follow-ons.
    Fox J
    Nat Biotechnol; 2008 Apr; 26(4):366. PubMed ID: 18392007
    [No Abstract]   [Full Text] [Related]  

  • 17. Engaging patients in medicines regulation: a tale of two agencies.
    Mavris M; Furia Helms A; Bere N
    Nat Rev Drug Discov; 2019 Nov; 18(12):885-886. PubMed ID: 31780842
    [No Abstract]   [Full Text] [Related]  

  • 18. Approval process and access to prescription drugs in Canada.
    Marra CA; Lynd LD; Anis AH; Esdaile JM
    Arthritis Rheum; 2006 Feb; 55(1):9-11. PubMed ID: 16463404
    [No Abstract]   [Full Text] [Related]  

  • 19. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 20. Italian police arrest drug agency officials over alleged falsification of data.
    Day M
    BMJ; 2008 May; 336(7655):1208-9. PubMed ID: 18511779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.